MedLife S.A.

M&A Activity • Feb 4, 2025

MedLife completes the acquisition of the Routine Med group from Tulcea

• Starting January 29, 2025, a new group of companies is part of the MedLife Group - Routine Med.
• According to the current shareholding structure, the majority stake – 60% – belongs to MedLife, and 40% is held by Mihai Pavel, the founder of the group.
• The acquisition was launched in October 2024 and completed at the beginning of this year.
• With this aquisition, patients in Dobrogea will be able to benefit, in addition to outpatient, imaging and laboratory services, from hospital services.

Bucharest, February 4, 2024: MedLife, the leader in the private healthcare market, announces the completion of the acquisition of Routine Med from Tulcea. As a result, the Group expands its national footprint in the southeast, where it is already present with collection points, a laboratory in Constanta, as well as three hyperclinics in Constanta, Galati and Braila, being the operator with the largest ecosystem of integrated diagnostic and treatment services in Romania.

The Routine Med group includes a hospital unit equipped with an operating room, a day and continuous hospitalization department, along with a generous outpatient area. Thus, patients in Dobrogea have access to over 20 medical and surgical specialties, including dentistry and medical optics. Hospital and outpatient services are complemented by laboratory and medical imaging services. According to company representatives, Routine Med's turnover in 2023 exceeded RON 15 million.

"Currently, if a patient in Romania wants to use MedLife services, they can reach a network unit within an hour's drive. We pride ourselves on being so close to those who need help and being the only private medical operator present with large hospitals or clinics in all cities with over 100,000 inhabitants. This does not mean that we neglect those in smaller towns, on the contrary, which is also attested by the acquisition of this group from Tulcea. Thanks to it, patients in southeastern Romania will benefit from over 20 medical and surgical specialties, including medical optics and dentistry", said Mihai Marcu President and CEO MedLife Group.

"We are pleased that Routine Med has evolved from modest beginnings - a laboratory founded in Sulina - to a group with a turnover of over three million euros. We know MedLife's history, we know that it has the largest acquisition portfolio on the Romanian medical market and we see the partnership with this group as a new and promising stage in the development of our business", said Mihai Pavel, founder of the Routine Med group from Tulcea.

***

About MedLife Group

MedLife started nearly three decades ago, growing steadily to become the largest provider of private medical services in Romania. Romanian entrepreneurs who founded the company invested and engaged to bring change to the Romanian healthcare system, believing in innovation and aiming high to offer Romanian patients quality, professionalism, care, and respect for their needs.

The company operates the most extensive network of clinics, one of the largest networks of medical laboratories, general and specialized hospitals, and has the largest corporate client base for Health Prevention Packages in the country. It is also one of the largest private healthcare service providers in Central and Eastern Europe in terms of sales.

MedLife Group has a successful track record in both organic growth and growth through acquisitions. Its strong and experienced management team has been able to create and manage growth opportunities, gaining valuable knowledge and experience to find the best path for successful expansion.

As a traditional Romanian company, MedLife chose to list on the Bucharest Stock Exchange, setting an example for local capital market listings. It has opened new horizons and, through its implemented corporate governance, has inspired other local companies to follow suit, contributing to the development of Romanian capital and the economy. MedLife SA shares are traded on the regulated market operated by the Bucharest Stock Exchange, in the Premium category, under the trading symbol "M".

During the pandemic period, MedLife played a crucial role in society and gained a leadership status in pandemic monitoring through active involvement in research.

The company continues to invest in projects with impact on the local community in technology and infrastructure. It creates jobs and develops an ecosystem that contributes to the development and maintenance of a healthy Romania.